The Source Blog
Recent Action in Healthcare Costs
HB 0815 (see companion bill SB 0755) – Tennessee
Introduced: 2023 Status: In Process
As introduced, requires certain individual and group health insurance policies to provide coverage of a continuous glucose monitor for a person with diabetes who is insulin-dependent and is covered by the policy. – Amends TCA …
SB 0755 (see companion HB 0815) – Tennessee
Introduced: 2023 Status: In Process
As introduced, requires certain individual and group health insurance policies to provide coverage of a continuous glucose monitor for a person with diabetes who is insulin-dependent and is covered by the policy. – Amends TCA …
SB 0666 (see companion bill HB 0885) – Tennessee
Introduced: 2023 Status: Inactive / Dead
As enacted, enacts the “Prior Authorization Fairness Act.” – Amends TCA Title 53; Title 56 and Title 71
HB 1213 (see companion bill SB 1392) – Tennessee
Introduced: 2023 Status: Inactive / Dead
As enacted, makes revisions to the Tennessee Right to Shop Act. – Amends TCA Title 8; Title 56 and Title 71.
SB 1392 (see companion bill HB 1213) – Tennessee
Introduced: 2023 Status: Enacted
As enacted, makes revisions to the Tennessee Right to Shop Act. – Amends TCA Title 8; Title 56 and Title 71.
HB 0377 (see companion bill SB 0585) – Tennessee
Introduced: 2023 Status: In Process
As introduced, enacts the “Patient Rights Act.” – Amends TCA Title 8; Title 29; Title 33; Title 34; Title 56; Title 63; Title 68 and Title 71.
SB 0585 (see companion bill HB 0377) – Tennessee
Introduced: 2023 Status: In Process
As introduced, enacts the “Patient Rights Act.” – Amends TCA Title 8; Title 29; Title 33; Title 34; Title 56; Title 63; Title 68 and Title 71.
Next | See all Legislation Records
Introduced: 2023 Status: In Process
As introduced, requires certain individual and group health insurance policies to provide coverage of a continuous glucose monitor for a person with diabetes who is insulin-dependent and is covered by the policy. – Amends TCA …
SB 0755 (see companion HB 0815) – Tennessee
Introduced: 2023 Status: In Process
As introduced, requires certain individual and group health insurance policies to provide coverage of a continuous glucose monitor for a person with diabetes who is insulin-dependent and is covered by the policy. – Amends TCA …
SB 0666 (see companion bill HB 0885) – Tennessee
Introduced: 2023 Status: Inactive / Dead
As enacted, enacts the “Prior Authorization Fairness Act.” – Amends TCA Title 53; Title 56 and Title 71
HB 1213 (see companion bill SB 1392) – Tennessee
Introduced: 2023 Status: Inactive / Dead
As enacted, makes revisions to the Tennessee Right to Shop Act. – Amends TCA Title 8; Title 56 and Title 71.
SB 1392 (see companion bill HB 1213) – Tennessee
Introduced: 2023 Status: Enacted
As enacted, makes revisions to the Tennessee Right to Shop Act. – Amends TCA Title 8; Title 56 and Title 71.
HB 0377 (see companion bill SB 0585) – Tennessee
Introduced: 2023 Status: In Process
As introduced, enacts the “Patient Rights Act.” – Amends TCA Title 8; Title 29; Title 33; Title 34; Title 56; Title 63; Title 68 and Title 71.
SB 0585 (see companion bill HB 0377) – Tennessee
Introduced: 2023 Status: In Process
As introduced, enacts the “Patient Rights Act.” – Amends TCA Title 8; Title 29; Title 33; Title 34; Title 56; Title 63; Title 68 and Title 71.
Next | See all Legislation Records
Braidwood Management Inc., et al. v. Becerra, et al. – Federal
District Court: Northern District of Texas Status: Pending
Braidwood Management, an organization that represents Christian businesses based in Texas, and a group of individuals from Texas filed a complaint to challenge parts of …
Community Hospitals and Wellness Centers v. State of Ohio – Ohio
District Court: Common Pleas Court of Williams County Status: Decided
Ohio’s Healthcare Price Transparency Law, passed in June 2015 (HB 52) by the Ohio Legislature, has been challenged by health care providers arguing that the …
Minnesota v. Sanofi-Aventis U.S. LLC – Minnesota
District Court: District Court of New Jersey Status: Pending
Minnesota’s attorney general filed a suit accusing Sanofi, Eli Lilly, and Novo Nordisk, the three largest manufacturers of insulin, of price gouging. The lawsuit, filed in …
Herrera et al. v. JFK Medical Center et al. – Florida
District Court: M.D. Florida Status: Decided
In August 2014, plaintiffs filed a putative class action against multiple HCA-operated hospitals in Tampa, alleging they were charged unreasonable amounts for emergency radiological services. …
Alcon Labs., Inc. v. Cottrell – New Jersey
District Court: District of New Jersey Status: Decided
Consumers brought putative class action against manufacturers and distributors of prescription eye medication, alleging they packaged medication in such a way as to force consumers …
In re Express Scripts/Anthem ERISA Litigation – New York
District Court: Southern District of New York Status: Pending
The district court dismissed a proposed class action against Anthem Inc. and Express Scripts Inc. over drug pricing methods, holding that the companies can’t be …
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
Next | See all Litigation Records
District Court: Northern District of Texas Status: Pending
Braidwood Management, an organization that represents Christian businesses based in Texas, and a group of individuals from Texas filed a complaint to challenge parts of …
Community Hospitals and Wellness Centers v. State of Ohio – Ohio
District Court: Common Pleas Court of Williams County Status: Decided
Ohio’s Healthcare Price Transparency Law, passed in June 2015 (HB 52) by the Ohio Legislature, has been challenged by health care providers arguing that the …
Minnesota v. Sanofi-Aventis U.S. LLC – Minnesota
District Court: District Court of New Jersey Status: Pending
Minnesota’s attorney general filed a suit accusing Sanofi, Eli Lilly, and Novo Nordisk, the three largest manufacturers of insulin, of price gouging. The lawsuit, filed in …
Herrera et al. v. JFK Medical Center et al. – Florida
District Court: M.D. Florida Status: Decided
In August 2014, plaintiffs filed a putative class action against multiple HCA-operated hospitals in Tampa, alleging they were charged unreasonable amounts for emergency radiological services. …
Alcon Labs., Inc. v. Cottrell – New Jersey
District Court: District of New Jersey Status: Decided
Consumers brought putative class action against manufacturers and distributors of prescription eye medication, alleging they packaged medication in such a way as to force consumers …
In re Express Scripts/Anthem ERISA Litigation – New York
District Court: Southern District of New York Status: Pending
The district court dismissed a proposed class action against Anthem Inc. and Express Scripts Inc. over drug pricing methods, holding that the companies can’t be …
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
Next | See all Litigation Records
News & Opinions
Articles & Reports
The Commonwealth Fund
September 19, 2023
JAMA Network September 18, 2023
JAMA Network September 18, 2023
Blue Health Intelligence September 14, 2023
JAMA Network September 18, 2023
JAMA Network September 18, 2023
Blue Health Intelligence September 14, 2023